Antisense Therapeutics Limited
Antisense Therapeutics Limited (ATHJF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATHJF · as of Jun 8, 2026
Key Statistics
Explore Antisense Therapeutics Limited Data
athjf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
athjf competitorsATHJF
BFFTF
GRAMF
KMSTF
NXTTF
OCELStock Performance
Full HistoryAbout Antisense Therapeutics Limited
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which i…
what is antisense therapeutics limited · athjf stock overview · antisense therapeutics limited company profile · who is antisense therapeutics limited ceo · athjf OTC · antisense therapeutics limited headquarters · antisense therapeutics limited business segments
About Stock Overview & Key Data
Antisense Therapeutics Limited (ATHJF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Sep 8, 2009. As of the latest trading session, ATHJF stock price is $0.01, with a market capitalization of $19.6M. The stock has returned -52.00% over the past 12 months and -52.00% year-to-date.
In fiscal year 2024, Antisense Therapeutics Limited reported revenue of $3.0M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Antisense Therapeutics Limited (ATHJF) stock price is $0.01. The stock is traded on OTC under the ticker symbol ATHJF. The 52-week range is $0.01 – $0.07.